Hikma Pharmaceuticals PLC (HIK)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

2,142.00p

Buy

2,146.00p

arrow-up16.00p (+0.75%)

Prices updated at 23 Jan 2025, 16:35 GMT

Prices minimum 15 mins delay

Prices in GBX

Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

FTSE All-Share

0.17%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2022	2023
	2,517m	2,875m
	1,238m	1,390m
	482m	604m
	19.15	21.01
	188m	190m
	485m	552m
Sales, General and administrative	615m	638m
Interest expenses	59m	73m
Provision for income taxes	42m	89m
Operating expenses	756m	786m
Income before taxes	233m	281m
Net income available to common shareholders	188m	190m
	0.839	0.86
Net interest income	-67m	-80m
Advertising and promotion	-	-
Net investment income, net	-27m	-9m
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	0.836	0.85
Free cash flow per share	1.1815	1.309
Book value/share	8.1962	7.7767
Debt equity ratio	0.531616	0.468608

Balance sheet

Year chevron-l-regular chevron-r-regular	2022	2023
Current assets	1,999m	2,100m
Current liabilities	1,077m	1,339m
Total capital	3,209m	3,173m
Total debt	1,283m	1,191m
Total equity	2,135m	2,198m
Total non current liabilities	-	-
Loans	1,074m	975m
Total assets	4,471m	4,680m
Total liabilities	-	-
Cash and cash equivalents	270m	205m
Common stock	220m	221m

Cash flow

Year chevron-l-regular chevron-r-regular	2022	2023
Cash at beginning of period	426m	270m
Cash dividends paid	-125m	-137m
	305m	533m
Investments (gains) losses	-607m	-333m
	270m	205m
Net income	-	-
	530m	737m
	-225m	-204m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.